1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. CRISPR THERAPEUTICS AG
CRISPR Therapeutics AG XNAS: CRSP

CRISPR Therapeutics AG Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Read More
54.80 0.48 (0.88%)
82.42% Gain from 52W Low
690.9K
XNAS Volume

XNAS 25 Aug, 2025 1:08 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
9.8 / 100
Momentum Score
Technically Neutral
47.9 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
82
1Yr Price target upside is 50%
23 analysts

8

S

7

W

4

O

1

T

SWOT Analysis

CRISPR Therapeutics AG Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..